Rick Bienkowski

Stock Analyst at Cantor Fitzgerald

(0.49)
# 4,138
Out of 5,044 analysts
35
Total ratings
25%
Success rate
-28.16%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Rick Bienkowski

Legend Biotech
May 14, 2025
Reiterates: Overweight
Price Target: $55
Current: $32.57
Upside: +68.87%
Beam Therapeutics
Mar 12, 2025
Reiterates: Overweight
Price Target: n/a
Current: $26.43
Upside: -
Arcellx
Sep 3, 2024
Initiates: Overweight
Price Target: n/a
Current: $87.49
Upside: -
Intellia Therapeutics
Jun 24, 2024
Reiterates: Overweight
Price Target: $65
Current: $13.96
Upside: +365.62%
Caribou Biosciences
Nov 8, 2023
Initiates: Neutral
Price Target: n/a
Current: $2.47
Upside: -
Editas Medicine
Sep 13, 2023
Reiterates: Overweight
Price Target: $14
Current: $3.17
Upside: +341.64%
CRISPR Therapeutics AG
Aug 8, 2022
Maintains: Outperform
Price Target: $112$107
Current: $64.17
Upside: +66.74%